[email protected]
CAS 128596-80-5 3′-Sialyllactose Sodium Salt molecular structure lightbox
CAS RN: 128596-80-5

3′-Sialyllactose Sodium Salt

Product Availability

Choose a grade to view its available package options.

7 package records7 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260504 100mg In stock Shanghai, Chengdu Inquiry
Batchno.20250306 1g In stock Shanghai Inquiry
Batchno.20250207 250mg In stock Shanghai, Tianjin Inquiry
Batchno.20251231 50mg In stock Shanghai Inquiry
Batchno.20251013 5g In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260131 100mg In stock Shanghai, Guangdong Inquiry
Batchno.20251201 20mg In stock Shanghai, Hebei Inquiry
  • Product code: SSC-035822
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.1g, 0.25g, 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 128596-80-5
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.1g ≥95% 0 Out of Stock Beijing Inquiry
0.25g ≥95% 0 Out of Stock Beijing Inquiry
1g ≥95% 0 Out of Stock Hong Kong Inquiry

128596-80-5 / sodium (2S,4S,5R,6R)-5-acetamido-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate

Standard CAS: 128596-80-5 Multi CAS: No
Basic Information Computed Properties Safety & Transport

Basic Information

CAS
128596-80-5
Multi CAS
No
Molecular Formula
C23H38NNaO19
Molecular Weight
655.500000
Exact Mass
655.193572
SMILES
CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)[O-])O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)CO)O)O.[Na+]
InChI
InChI=1S/C23H39NO19.Na/c1-7(29)24-13-8(30)2-23(22(38)39,42-19(13)15(35)10(32)4-26)43-20-16(36)12(6-28)40-21(17(20)37)41-18(11(33)5-27)14(34)9(31)3-25;/h3,8-21,26-28,30-37H,2,4-6H2,1H3,(H,24,29)(H,38,39);/q;+1/p-1/t8-,9-,10+,11+,12+,13+,14+,15+,16-,17+,18+,19+,20-,21-,23-;/m0./s1
InChIKey
LTWFUJWFLMHANB-TZCPRLTCSA-M

Computed Properties

Structural Parameters

Heavy atom count
44
Fraction Csp3
0.87
Rotatable bonds
15
H-bond acceptors
19
H-bond donors
12
Molar refractivity
128.62
TPSA
345.75

LogP / Solubility

WLOGP
-12.71
MLOGP
-11.13
XLogP3
-12.71
Consensus LogP
-12.18
Log S (ESOL)
5.09
Class (ESOL)
Highly soluble
Log S (Ali)
4.24
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
4.83
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-15.74

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Customers Also Viewed

Get In Touch

Contact Us